A Teaching Model for Aromatase Inhibitors After Tamoxifen

• Published in: Journal of cancer education Vol. 25; no. 4; pp. 493 - 496
• Main Authors: Trotter, Theresa, Webster, Marc, Railton, Cindy, Paterson, A. H. G., Donnon, Tyrone
• Format: Journal Article
• Language: English
• Published: New York Springer-Verlag 01.12.2010; Springer Nature B.V
• Subjects: Antineoplastic Agents, Hormonal - therapeutic use; Aromatase Inhibitors - therapeutic use; Biomedical and Life Sciences; Biomedicine; Breast cancer; Breast Neoplasms - drug therapy; Cancer; Cancer Research; Case Studies; Chemotherapy, Adjuvant; Clinical Competence; Community Relations; Content Validity; Education, Medical, Continuing; Family physicians; Female; Females; Health education; Hormone replacement therapy; Humans; Medical Education; Meta Analysis; Models, Educational; Multivariate Analysis; Patients; Pharmacology/Toxicology; Physicians; Physicians, Family - education; Postmenopause; Predictive Validity; Pretests Posttests; Professional Continuing Education; Special Programs; Tamoxifen - therapeutic use; Teaching Methods; Teaching Models; Validity; Workshops; Physician; Teaching model; Tamoxifen; Letrozole; Aromatase inhibitors
• ISSN: 0885-8195; 1543-0154
• DOI: 10.1007/s13187-010-0095-9

Breast cancer is the most common cancer diagnosed in women. The present study evaluated the family physicians' (FPs) understanding of adjuvant hormonal therapies for an early breast cancer. FPs were invited to attend teaching workshops on this topic, which utilized a pretest, didactic and interactive teaching, and posttest format. FPs ( n  = 23) showed an improvement ( p  < 0.001) in pretest to posttest score. It is clear that, with a targeted teaching, FPs can quickly become more knowledgeable on the topic of hormonal therapies in breast cancer, with the potential of applying this information in their own practice.